Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
about
Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials.
P2860
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@ast
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@en
type
label
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@ast
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@en
prefLabel
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@ast
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@en
P2093
P2860
P50
P1433
P1476
Preoperative chemoradiation wi ...... 402, randomized phase 2 trial.
@en
P2093
Amaury Paumier
Andrew Kramar
Antoine Adenis
Christophe Mariette
Emmanuelle Tresch
Farid El Hajbi
Frederique Vasseur
Guillaume Piessen
Laetitia Dahan
Mathieu Messager
P2860
P2888
P356
10.1186/S12885-016-2335-9
P407
P577
2016-05-18T00:00:00Z
P6179
1035707552